The GLP-1 Blockbuster Maker Widens Its Lead as the Diversified Healthcare Giant Posts Steady Growth
jetcityimage / iStock Editorial via Getty Images Lilly posted 53.9% revenue growth and 480% net income growth driven…
Amazon Adds Novo Nordisk’s Wegovy Pill to Pharmacy Platform
This article first appeared on GuruFocus. Amazon Pharmacy (AMZN, Financials) stated that it is now selling Novo Nordisk’s…
New Wegovy pill offers weight loss alternative to injections
WILMINGTON, N.C. (WECT) – A new weight loss option is now available for people seeking alternatives to weekly…
Companies can make generic Ozempic as of next week, but don’t expect to get it soon
TORONTO — Drug companies in Canada are allowed to make lower priced generic versions of the blockbuster drug…
Where Will Pfizer Be in 5 Years?
Pfizer’s stock soared during the coronavirus pandemic because of its COVID-19 vaccine. The world has learned to live…
Novo Nordisk just pulled off something nobody saw coming
Novo Nordisk just got a big win from the FDA, and it could change the weight-loss medicine industry…
New Oral Wegovy Pill Approved by FDA as Patients Compare Injectable and Compounded Access Pathways
Summary: Oral pills add flexibility; insurance coverage still varies widely, and compounded options remain unapproved. What “Best Semaglutide”…
Lilly and Novo Cut GLP-1 Prices as Pill Approvals Expand Access
This article first appeared on GuruFocus. Weight-loss drugs known as GLP-1s are increasingly reshaping healthcare and the pharmaceutical…
FDA approves weight loss drug in daily pill form
FDA approves weight loss drug in daily pill form – CBS News Watch CBS News Regulators at the…
Employers drop obesity drug coverage as cash-pay programs grow
When HCA Healthcare, one of the largest hospital systems in the U.S., recently told employees it would stop…
Popular weightloss drug Ozempic launched in India at the price of Rs…, check dosage, more details
Danish drugmaker Novo Nordisk launched its most popular weight-loss drug Ozempic in India on Friday. The price of…
High-Dose Wegovy Takes Aim at Lilly’s Zepbound
This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO) said its high-dose version of Wegovy has received a…